Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lignocaine Nebulization Versus Airway Block for Awake Nasal Fiberoptic Intubation in Patients With Head and Neck Burns. A Randomized Controlled Study.

NCT05550051 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05550051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05550051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lignocaine Nebulization Versus Airway Block for Awake Nasal Fiberoptic Intubation in Patients With Head and Neck Burns. A Randomized Controlled Study.
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Completed
Start date
September 23, 2022
Completion date
February 5, 2023
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

practicality, efficacy, and ease of lignocaine nebulization compared to traditional upper airway block for awake nasal fiberoptic intubation